Literature DB >> 10944856

Molecular and structural studies of Japanese patients with sialidosis type 1.

Y Naganawa1, K Itoh, M Shimmoto, K Takiguchi, H Doi, Y Nishizawa, T Kobayashi, S Kamei, K E Lukong, A V Pshezhetsky, H Sakuraba.   

Abstract

To gain insight into the pathogenesis of sialidosis type 1, we performed molecular investigations of two unrelated Japanese patients. Both of them are compound heterozygotes for base substitutions of 649G-to-A and 727G-to-A, which result in amino acid alterations V217M and G243R, respectively. Using homology modeling, the structure of human lysosomal neuraminidase was constructed and the structural changes caused by these missense mutations were deduced. The predicted change due to V217M was smaller than that caused by G243R, the latter resulting in a drastic, widespread alteration. The overexpressed gene products containing these mutations had the same molecular weight as that of the wild type, although the amounts of the products were moderately decreased. A biochemical study demonstrated that the expressed neuraminidase containing a V217M mutation was partly transported to lysosomes and showed residual enzyme activity, although a G243R mutant was retained in the endoplasmic reticulum/Golgi area and had completely lost the enzyme activity. Considering the data, we surmise that the V217M substitution may be closely associated with the phenotype of sialidosis type 1 with a late onset and moderate clinical course.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944856     DOI: 10.1007/s100380070034

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  9 in total

1.  Sialidosis type I with neoplasms in siblings: the first clinical cases.

Authors:  Yohsuke Yagi; Akira Machida; Shuta Toru; Takayoshi Kobayashi; Toshiki Uchihara
Journal:  Neurol Sci       Date:  2010-08-13       Impact factor: 3.307

2.  Clinical and genetic characteristics of type I sialidosis patients in mainland China.

Authors:  Rui-Juan Lv; Tao-Ran Li; Yu-Di Zhang; Xiao-Qiu Shao; Qun Wang; Li-Ri Jin
Journal:  Ann Clin Transl Neurol       Date:  2020-05-29       Impact factor: 4.511

Review 3.  Recent development in mammalian sialidase molecular biology.

Authors:  Eugenio Monti; Augusto Preti; Bruno Venerando; Giuseppe Borsani
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

4.  In silico identification of new putative pathogenic variants in the NEU1 sialidase gene affecting enzyme function and subcellular localization.

Authors:  Dario Bonardi; Viola Ravasio; Giuseppe Borsani; Alessandra d'Azzo; Roberto Bresciani; Eugenio Monti; Edoardo Giacopuzzi
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

5.  Genetic and clinical characterization of mainland Chinese patients with sialidosis type 1.

Authors:  Xiaoxu Han; Shijing Wu; Min Wang; Hui Li; Yan Huang; Ruifang Sui
Journal:  Mol Genet Genomic Med       Date:  2020-05-26       Impact factor: 2.183

6.  Compound heterozygous mutations in the neuraminidase 1 gene in type 1 sialidosis: A case report and review of literature.

Authors:  Lan-Xiao Cao; Ying Liu; Zhao-Jun Song; Bao-Rong Zhang; Wen-Ying Long; Guo-Hua Zhao
Journal:  World J Clin Cases       Date:  2021-01-26       Impact factor: 1.337

7.  Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis.

Authors:  Alessandra d'Azzo; Eda Machado; Ida Annunziata
Journal:  Expert Opin Orphan Drugs       Date:  2015-04-13       Impact factor: 0.694

8.  Conventional and Unconventional Therapeutic Strategies for Sialidosis Type I.

Authors:  Rosario Mosca; Diantha van de Vlekkert; Yvan Campos; Leigh E Fremuth; Jaclyn Cadaoas; Vish Koppaka; Emil Kakkis; Cynthia Tifft; Camilo Toro; Simona Allievi; Cinzia Gellera; Laura Canafoglia; Gepke Visser; Ida Annunziata; Alessandra d'Azzo
Journal:  J Clin Med       Date:  2020-03-04       Impact factor: 4.241

Review 9.  Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms.

Authors:  Parvaneh Karimzadeh; Mohammad Ghofrani; Shahram Nasiri
Journal:  Iran J Child Neurol       Date:  2020
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.